Compare SLDP & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SLDP | CBLL |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | 230 | 280 |
| Industry | Electrical Products | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.3M | 750.1M |
| IPO Year | N/A | N/A |
| Metric | SLDP | CBLL |
|---|---|---|
| Price | $3.46 | $20.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.00 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 5.8M | 214.5K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | $48.90 | $28.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $10.85 |
| 52 Week High | $8.86 | $24.33 |
| Indicator | SLDP | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 53.00 |
| Support Level | $3.43 | $18.78 |
| Resistance Level | $4.18 | $21.80 |
| Average True Range (ATR) | 0.28 | 0.77 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 25.26 | 48.66 |
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.